The UK’s Food Standards Agency (FSA) has issued the first two ‘positive safety assessments’ for CBD (cannabidiol) products as part of its years-long novel foods authorisation...
A crowdfunder aims to raise £20,000 to undertake public relations and promotional activity around the existence and benefits of prescription cannabis.
The move will enable individuals with conditions such as anxiety, ADHD or PTSD to access treatment through Treat It clinic.
Cristelle Santos, consultant toxicologist at Broughton Group, shares her experiences as a toxicologist in the CBD sector.
Cash has described CBD as a ‘gamechanger’ for athletes living with chronic pain.
Libby Clarke, managing consultant for Toxicology at Broughton, explores how CBD companies can optimise their testing strategies.
The Cannabis Industry Council has joined over 11,000 other organisations across the country in signing the Armed Forces Covenant.
We asked experts in the European cannabis sector about their predictions for 2024.
Global sales of adult-use cannabis are projected to double worldwide by 2027.
Leaders have assured patients that all aspects of operations, services, and leadership will remain unchanged.
